img

Global Rho-kinase Inhibitor Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rho-kinase Inhibitor Market Research Report 2024

Rho-kinase inhibitors (rho-associated protein kinase inhibitor or ROCK inhibitor) are a series of compounds that target rho kinase (ROCK) and inhibit the ROCK pathway
According to Mr Accuracy reports’s new survey, global Rho-kinase Inhibitor market is projected to reach US$ 264.3 million in 2029, increasing from US$ 169.8 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rho-kinase Inhibitor market research.
The Rho-kinase inhibitor market has been driven by its potential therapeutic benefits in various diseases, including hypertension, glaucoma, and pulmonary arterial hypertension. Rho-kinase inhibitors' ability to modulate cellular processes and improve vascular function has garnered significant interest among researchers and healthcare professionals. Additionally, the growing geriatric population and increasing prevalence of these diseases have further propelled market growth. However, challenges persist, including the need for extensive clinical trials to establish safety and efficacy, potential off-target effects, and the complexities of drug development, hindering the market's full potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rho-kinase Inhibitor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Kowa Pharmaceuticals
Senju Pharmaceutical
Novartis
AERIE PHARMACEUTICALS
Redx Pharma
Segment by Type
Netarsudil
Ripasudil Hydrochloride Hydrate
Fasudil
Others

Segment by Application


Cerebral Vasospasm
Glaucoma
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Rho-kinase Inhibitor report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rho-kinase Inhibitor Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Netarsudil
1.2.3 Ripasudil Hydrochloride Hydrate
1.2.4 Fasudil
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rho-kinase Inhibitor Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cerebral Vasospasm
1.3.3 Glaucoma
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rho-kinase Inhibitor Market Perspective (2018-2029)
2.2 Rho-kinase Inhibitor Growth Trends by Region
2.2.1 Global Rho-kinase Inhibitor Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rho-kinase Inhibitor Historic Market Size by Region (2018-2024)
2.2.3 Rho-kinase Inhibitor Forecasted Market Size by Region (2024-2029)
2.3 Rho-kinase Inhibitor Market Dynamics
2.3.1 Rho-kinase Inhibitor Industry Trends
2.3.2 Rho-kinase Inhibitor Market Drivers
2.3.3 Rho-kinase Inhibitor Market Challenges
2.3.4 Rho-kinase Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rho-kinase Inhibitor Players by Revenue
3.1.1 Global Top Rho-kinase Inhibitor Players by Revenue (2018-2024)
3.1.2 Global Rho-kinase Inhibitor Revenue Market Share by Players (2018-2024)
3.2 Global Rho-kinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rho-kinase Inhibitor Revenue
3.4 Global Rho-kinase Inhibitor Market Concentration Ratio
3.4.1 Global Rho-kinase Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rho-kinase Inhibitor Revenue in 2022
3.5 Rho-kinase Inhibitor Key Players Head office and Area Served
3.6 Key Players Rho-kinase Inhibitor Product Solution and Service
3.7 Date of Enter into Rho-kinase Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rho-kinase Inhibitor Breakdown Data by Type
4.1 Global Rho-kinase Inhibitor Historic Market Size by Type (2018-2024)
4.2 Global Rho-kinase Inhibitor Forecasted Market Size by Type (2024-2029)
5 Rho-kinase Inhibitor Breakdown Data by Application
5.1 Global Rho-kinase Inhibitor Historic Market Size by Application (2018-2024)
5.2 Global Rho-kinase Inhibitor Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rho-kinase Inhibitor Market Size (2018-2029)
6.2 North America Rho-kinase Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rho-kinase Inhibitor Market Size by Country (2018-2024)
6.4 North America Rho-kinase Inhibitor Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rho-kinase Inhibitor Market Size (2018-2029)
7.2 Europe Rho-kinase Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rho-kinase Inhibitor Market Size by Country (2018-2024)
7.4 Europe Rho-kinase Inhibitor Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rho-kinase Inhibitor Market Size (2018-2029)
8.2 Asia-Pacific Rho-kinase Inhibitor Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rho-kinase Inhibitor Market Size by Region (2018-2024)
8.4 Asia-Pacific Rho-kinase Inhibitor Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rho-kinase Inhibitor Market Size (2018-2029)
9.2 Latin America Rho-kinase Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rho-kinase Inhibitor Market Size by Country (2018-2024)
9.4 Latin America Rho-kinase Inhibitor Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rho-kinase Inhibitor Market Size (2018-2029)
10.2 Middle East & Africa Rho-kinase Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rho-kinase Inhibitor Market Size by Country (2018-2024)
10.4 Middle East & Africa Rho-kinase Inhibitor Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kowa Pharmaceuticals
11.1.1 Kowa Pharmaceuticals Company Detail
11.1.2 Kowa Pharmaceuticals Business Overview
11.1.3 Kowa Pharmaceuticals Rho-kinase Inhibitor Introduction
11.1.4 Kowa Pharmaceuticals Revenue in Rho-kinase Inhibitor Business (2018-2024)
11.1.5 Kowa Pharmaceuticals Recent Development
11.2 Senju Pharmaceutical
11.2.1 Senju Pharmaceutical Company Detail
11.2.2 Senju Pharmaceutical Business Overview
11.2.3 Senju Pharmaceutical Rho-kinase Inhibitor Introduction
11.2.4 Senju Pharmaceutical Revenue in Rho-kinase Inhibitor Business (2018-2024)
11.2.5 Senju Pharmaceutical Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Rho-kinase Inhibitor Introduction
11.3.4 Novartis Revenue in Rho-kinase Inhibitor Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 AERIE PHARMACEUTICALS
11.4.1 AERIE PHARMACEUTICALS Company Detail
11.4.2 AERIE PHARMACEUTICALS Business Overview
11.4.3 AERIE PHARMACEUTICALS Rho-kinase Inhibitor Introduction
11.4.4 AERIE PHARMACEUTICALS Revenue in Rho-kinase Inhibitor Business (2018-2024)
11.4.5 AERIE PHARMACEUTICALS Recent Development
11.5 Redx Pharma
11.5.1 Redx Pharma Company Detail
11.5.2 Redx Pharma Business Overview
11.5.3 Redx Pharma Rho-kinase Inhibitor Introduction
11.5.4 Redx Pharma Revenue in Rho-kinase Inhibitor Business (2018-2024)
11.5.5 Redx Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Rho-kinase Inhibitor Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Netarsudil
Table 3. Key Players of Ripasudil Hydrochloride Hydrate
Table 4. Key Players of Fasudil
Table 5. Key Players of Others
Table 6. Global Rho-kinase Inhibitor Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Rho-kinase Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Rho-kinase Inhibitor Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Rho-kinase Inhibitor Market Share by Region (2018-2024)
Table 10. Global Rho-kinase Inhibitor Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Rho-kinase Inhibitor Market Share by Region (2024-2029)
Table 12. Rho-kinase Inhibitor Market Trends
Table 13. Rho-kinase Inhibitor Market Drivers
Table 14. Rho-kinase Inhibitor Market Challenges
Table 15. Rho-kinase Inhibitor Market Restraints
Table 16. Global Rho-kinase Inhibitor Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Rho-kinase Inhibitor Market Share by Players (2018-2024)
Table 18. Global Top Rho-kinase Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rho-kinase Inhibitor as of 2022)
Table 19. Ranking of Global Top Rho-kinase Inhibitor Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Rho-kinase Inhibitor Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Rho-kinase Inhibitor Product Solution and Service
Table 23. Date of Enter into Rho-kinase Inhibitor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rho-kinase Inhibitor Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Rho-kinase Inhibitor Revenue Market Share by Type (2018-2024)
Table 27. Global Rho-kinase Inhibitor Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Rho-kinase Inhibitor Revenue Market Share by Type (2024-2029)
Table 29. Global Rho-kinase Inhibitor Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Rho-kinase Inhibitor Revenue Market Share by Application (2018-2024)
Table 31. Global Rho-kinase Inhibitor Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Rho-kinase Inhibitor Revenue Market Share by Application (2024-2029)
Table 33. North America Rho-kinase Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Rho-kinase Inhibitor Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Rho-kinase Inhibitor Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Rho-kinase Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Rho-kinase Inhibitor Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Rho-kinase Inhibitor Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Rho-kinase Inhibitor Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Rho-kinase Inhibitor Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Rho-kinase Inhibitor Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Rho-kinase Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Rho-kinase Inhibitor Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Rho-kinase Inhibitor Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rho-kinase Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Rho-kinase Inhibitor Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Rho-kinase Inhibitor Market Size by Country (2024-2029) & (US$ Million)
Table 48. Kowa Pharmaceuticals Company Detail
Table 49. Kowa Pharmaceuticals Business Overview
Table 50. Kowa Pharmaceuticals Rho-kinase Inhibitor Product
Table 51. Kowa Pharmaceuticals Revenue in Rho-kinase Inhibitor Business (2018-2024) & (US$ Million)
Table 52. Kowa Pharmaceuticals Recent Development
Table 53. Senju Pharmaceutical Company Detail
Table 54. Senju Pharmaceutical Business Overview
Table 55. Senju Pharmaceutical Rho-kinase Inhibitor Product
Table 56. Senju Pharmaceutical Revenue in Rho-kinase Inhibitor Business (2018-2024) & (US$ Million)
Table 57. Senju Pharmaceutical Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Rho-kinase Inhibitor Product
Table 61. Novartis Revenue in Rho-kinase Inhibitor Business (2018-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. AERIE PHARMACEUTICALS Company Detail
Table 64. AERIE PHARMACEUTICALS Business Overview
Table 65. AERIE PHARMACEUTICALS Rho-kinase Inhibitor Product
Table 66. AERIE PHARMACEUTICALS Revenue in Rho-kinase Inhibitor Business (2018-2024) & (US$ Million)
Table 67. AERIE PHARMACEUTICALS Recent Development
Table 68. Redx Pharma Company Detail
Table 69. Redx Pharma Business Overview
Table 70. Redx Pharma Rho-kinase Inhibitor Product
Table 71. Redx Pharma Revenue in Rho-kinase Inhibitor Business (2018-2024) & (US$ Million)
Table 72. Redx Pharma Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rho-kinase Inhibitor Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Rho-kinase Inhibitor Market Share by Type: 2022 VS 2029
Figure 3. Netarsudil Features
Figure 4. Ripasudil Hydrochloride Hydrate Features
Figure 5. Fasudil Features
Figure 6. Others Features
Figure 7. Global Rho-kinase Inhibitor Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Rho-kinase Inhibitor Market Share by Application: 2022 VS 2029
Figure 9. Cerebral Vasospasm Case Studies
Figure 10. Glaucoma Case Studies
Figure 11. Others Case Studies
Figure 12. Rho-kinase Inhibitor Report Years Considered
Figure 13. Global Rho-kinase Inhibitor Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Rho-kinase Inhibitor Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Rho-kinase Inhibitor Market Share by Region: 2022 VS 2029
Figure 16. Global Rho-kinase Inhibitor Market Share by Players in 2022
Figure 17. Global Top Rho-kinase Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rho-kinase Inhibitor as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Rho-kinase Inhibitor Revenue in 2022
Figure 19. North America Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Rho-kinase Inhibitor Market Share by Country (2018-2029)
Figure 21. United States Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Rho-kinase Inhibitor Market Share by Country (2018-2029)
Figure 25. Germany Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Rho-kinase Inhibitor Market Share by Region (2018-2029)
Figure 33. China Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Rho-kinase Inhibitor Market Share by Country (2018-2029)
Figure 41. Mexico Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Rho-kinase Inhibitor Market Share by Country (2018-2029)
Figure 45. Turkey Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Rho-kinase Inhibitor Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Kowa Pharmaceuticals Revenue Growth Rate in Rho-kinase Inhibitor Business (2018-2024)
Figure 48. Senju Pharmaceutical Revenue Growth Rate in Rho-kinase Inhibitor Business (2018-2024)
Figure 49. Novartis Revenue Growth Rate in Rho-kinase Inhibitor Business (2018-2024)
Figure 50. AERIE PHARMACEUTICALS Revenue Growth Rate in Rho-kinase Inhibitor Business (2018-2024)
Figure 51. Redx Pharma Revenue Growth Rate in Rho-kinase Inhibitor Business (2018-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries